It is likely that CNM's prescriptive privileges will, in the near future, cover mifepristone and misoprostol.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/CFCE552D.svg?ark=w1%2F20260515%2FCFCE552D)](https://nobleid.org/work/w1/20260515/CFCE552D)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors